CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Stem Cells

Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.

Subtype terms (11)

More specific conditions that are subtypes of Stem Cells in the MeSH hierarchy.

  • Adult Stem Cells

    2 drugs experimental

  • Fetal Stem Cells
  • Hematopoietic Stem Cells

    9 drugs (8 approved, 1 experimental)

  • Multipotent Stem Cells
  • Myoblasts
  • Neoplastic Stem Cells

    1 drug approved

  • Neural Stem Cells
  • Oogonial Stem Cells
  • Pluripotent Stem Cells
  • Side-Population Cells
  • Totipotent Stem Cells

Drugs by status

Phase 4 trials (3)

  • Anti-thymocyte Globulin (Rabbit)
  • umbilical cord mesenchymal stem cells
  • triamcinolone

Phase 3 trials (2)

  • wharton's jelly mesenchymal stem cells
  • insulin producing stem cells

Phase 2 trials (13)

  • plerixafor
  • cdx-301
  • hyaluronic acid
  • ruxolitinib
  • allogeneic adipose derived mesenchymal stem cell
  • autologous skin fibroblasts
  • human fecal microbiota
  • human placental derived stem cells
  • limbal epithelial stem cell graft
  • mucosal cell
  • Allogeneic ABCB5-positive Limbal Stem Cells
  • mrg001
  • sar445419

Phase 1 trials (11)

  • amniotic membrane
  • bkt-140
  • lenalidomide
  • bone marrow derived mesenchymal stem cells
  • Filgrastim
  • allogeneic hematopoietic stem cells
  • autologous limbal epithelial cell
  • stemchymal
  • autologous mononuclear stem cell
  • adipose mesenchymal stem cell conditioned media
  • csb-001

Other trials (4)

  • nicotinamide
  • oral mucosal epithelial cell
  • stromal vascular fraction
  • autologous adipose-derived mesenchymal stem cells

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.